Generation LNP Advancements enhance potency and safety, expand delivery beyond the liver, and enable broader therapeutic ...

Moderna stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return.

At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...

Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...

New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.

近日，智飞生物全资子公司安徽智飞龙科马自主研发的 带状疱疹mRNA疫苗临床试验申请正式获得国家药品监督管理局受理 ...

The U.S. Senate’s Permanent Subcommittee on Investigations held a crucial hearing titled "The Corruption of Science and ...

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of uncertainty, scientists worry that revolutionary treatments for cancer, immune ...

近年来，癌症“治疗性疫苗”成为全球肿瘤免疫治疗中增长最快的领域。我国自主研发的 新生抗原mRNA癌症疫苗LK101已获得了美国FDA临床试验批件 ，此外LK101也在多项临床研究中展现出可观的抗肿瘤活性。在2024年ASCO ...

Donald Trump's health is once again under scrutiny after it was revealed that he received three mRNA injections linked to ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...